A detailed history of Deka Bank Deutsche Girozentrale transactions in Insmed Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 50,000 shares of INSM stock, worth $3.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$3.5 Million
Previous $3.35 Million 7.46%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 24, 2023

SELL
$16.26 - $21.73 $790,236 - $1.06 Million
-48,600 Reduced 49.29%
50,000 $831,000
Q1 2022

Apr 28, 2022

SELL
$20.42 - $28.13 $888,270 - $1.22 Million
-43,500 Reduced 30.61%
98,600 $2.26 Million
Q4 2021

Feb 02, 2022

BUY
$25.89 - $33.45 $204,531 - $264,255
7,900 Added 5.89%
142,100 $3.87 Million
Q1 2021

Apr 28, 2021

BUY
$32.28 - $44.3 $112,980 - $155,050
3,500 Added 2.68%
134,200 $4.32 Million
Q4 2020

Mar 12, 2021

BUY
$31.45 - $40.54 $462,315 - $595,938
14,700 Added 12.67%
130,700 $4.37 Million
Q3 2020

Oct 29, 2020

BUY
$26.0 - $34.5 $3.02 Million - $4 Million
116,000 New
116,000 $3.73 Million
Q4 2019

Feb 04, 2020

SELL
$16.12 - $24.98 $417,508 - $646,982
-25,900 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $401,191 - $667,702
-25,900 Reduced 50.0%
25,900 $473,000
Q2 2019

Aug 01, 2019

BUY
$23.0 - $32.19 $420,900 - $589,077
18,300 Added 54.63%
51,800 $1.31 Million
Q1 2019

May 10, 2019

SELL
$13.91 - $31.15 $33,384 - $74,760
-2,400 Reduced 6.69%
33,500 $731,000
Q4 2018

Feb 12, 2019

BUY
$11.6 - $18.7 $27,840 - $44,880
2,400 Added 7.16%
35,900 $467,000
Q3 2018

Nov 09, 2018

SELL
$18.95 - $28.08 $17,055 - $25,272
-900 Reduced 2.62%
33,500 $0
Q1 2018

May 03, 2018

SELL
$21.69 - $32.99 $15,183 - $23,093
-700 Reduced 1.99%
34,400 $758,000
Q3 2017

Nov 06, 2017

BUY
$11.61 - $31.21 $407,511 - $1.1 Million
35,100
35,100 $411,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.